Bharatbook added a new report on "Pharmaceutical Brand PR: Developing
Engaging Campaigns and Measuring ROI, FirstWord goes directly to the experts to
determine key factors in what makes PR campaigns buzz. "

The value of PR can seem immeasurable in brand positioning. Yet, in an age of
budgetary juggling by marketing departments, the drive to scrutinize ROI is
increasingly important. What’s more, as expectations on PR outcomes increase—in
part due to social media—its role is broadening. A trend towards using key
performance indicators to measure previously difficult-to-define notions of
success is emerging.

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/pharmaceutical-brand-pr-developing-engaging-campaigns-and-measuring-roi.html

Report Overview
In Pharmaceutical Brand PR: Developing Engaging Campaigns and Measuring ROI,
FirstWord goes directly to the experts to determine key factors in what makes PR
campaigns buzz and how tightened budgets but greater expectations have changed
the way PR work is mandated. The report also examines the role of PR versus
advertising and how, through social media, PR has become increasingly
sophisticated to position brands across multiple channels and audiences. But
mostly compelling, it dissects why—and how—ROI can be measured and how such
information can deliver more insight than just numbers.
market research book

Key features
* Examination of strategies for measuring ROI in PR campaigns
* PR’s evolution in engaging multiple audiences and working for a brand
* Detailed research into what works—and what doesn’t—in PR
* The role of social media in PR and ROI measurement
* Insight into what other benefits ROI offers
* Experts views on the role of PR versus advertising and if the ratio should
change

Key Benefits
* A full breakdown of the role of PR in the marketing mix
* Clear insight into quantifying ROI and developing measurement criteria
* Access to expert opinion from key leaders in the industry

For more information kindly visit :  Pharmaceutical
Brand PR: Developing Engaging Campaigns and Measuring ROI

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Pharma Marketing Excellence: Lessons from
Experience, FirstWord reviews the role of marketing excellence strategies, what
they entail and why they have been integrated into the wider landscape of
competency development "

Marketing excellence. Over the past five years, those two words have been the
subject of hype and the focus of management attention. As the pharmaceutical
industry struggles with market maturation and weakening product pipelines,
marketing excellence programmes have been developed and implemented with an eye
to overcoming those hurdles.

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/pharma-marketing-excellence-lessons-from-experience.html

But how well are they working and is there one optimal model for their use?
There is no question that such programmes are costly—even low-cost examples have
a high ‘opportunity cost’. In balancing those costs with benefit, the past five
years have yielded important lessons that will now influence the future of
marketing excellence. market research book

Report Overview
In Pharma Marketing Excellence: Lessons from Experience, FirstWord reviews
the role of marketing excellence strategies, what they entail and why they have
been integrated into the wider landscape of competency development and marketing
strategies. In reviewing the experiences of five companies, the report reveals a
four-archetype model, establishes seven key lessons for those implementing
programmes and offers real solutions to not only avoid failure, but ensure
success.

Key features
* Five cases studies offering ground-up insight into marketing excellence

* A four-archetype model for programmes and clear explanation of their best fit

* Seven key lessons for executives implementing marketing excellence
* Explanation of implications for companies considering their implementation
* Overview of what marketing excellence strategies involve, their cost and
benefits

Key Benefits
* Full examination of marketing excellence, how it works, why it’s
implemented
* Review of key lessons taken from current and past programmes
* How companies choose programme content and models dependent upon need

Key quotes
“Unfortunately, marketing excellence is often a reaction to a significant
mistake. One firm we worked with was driven to develop a programme focused on
clinical development after a product failed approval, which was of course a very
expensive and avoidable mistake.” – Kurt Kessler, ZS Associates
“Whilst the concepts are, in principle, quite simple, the devil is in the detail
of how it is applied in the context of the real world.” – Wim Souverijns,
Celgene
“It is about more than just being granted a budget and given an objective. The
key to success is to have the senior management team develop a shared vision of
the programme.” – Theo Nieuwenhuis, Boehringer Ingelheim


For more information kindly visit :  Pharma
Marketing Excellence: Lessons from Experience

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Payer Agreements: Splitting the Risk,
FirstWord Dossier offers a complete and concise overview of payer schemes by
definition and category. "

Budgets are tight. Payer funding for new products is dwindling. And for
pharmaceutical companies, market access is more and more difficult to attain.
Across the UK, the US, Canada, Australia and parts of Europe, payer schemes are
increasingly de rigueur. Schemes advanced by pharmaceutical companies either aim
to grapple financial issues such as price volume agreements, or they tackle
uncertainty by addressing increased data collection.

http://www.bharatbook.com/market-research-reports/business-forecast-outlook-market-research-report/payer-agreements-splitting-the-risk.html

Report Overview
In Payer Agreements: Splitting the Risk, FirstWord Dossier offers a complete
and concise overview of payer schemes by definition and category. Based on an
array of expert interviews, the report discusses the key drivers behind the
evolution of payer schemes from financial imperatives to market uncertainty.
Most importantly, the report defines—country by country—emerging trends based on
current case studies and tackles the big question: What are the key features
that will ensure success? market research
book

Key features
* Detailed examination of the role of agreements in global pricing,
reimbursement and market access
* Discussion of the drivers for schemes, including HTA and financial challenges
* Country-by-country trends illustrated with case studies
* Expert insight into the role of schemes and their evolution
* Analysis of the pros and cons of agreements

Key Benefits
* Definitions and categories of schemes
* Expert insight from key regulatory bodies
* Comprehensive references to key literature

Key Questions Asked
* What principles should be used in designing schemes?
* When should companies offer risk-sharing agreements?
* How can European risk-sharing be implemented in the US?
* What is the current state of play with schemes globally?
* What changes are likely in the future?

Who Should Read This Report
* Market access directors and managers
* Health economics professionals
* Pharmacoeconomics professionals
* Health Outcomes / Outcomes Research professionals
* Pricing and Reimbursement teams
* Government and regulatory affairs analysts
* Marketing research/business intelligence managers
* Government and regulatory affairs analysts

For more information kindly visit :  Payer
Agreements: Splitting the Risk

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Observing Patients Online: the changing
face of research, FirstWord investigates the role online patient communities can
play in observational research to enhance knowledge of how drugs are taken in
the real world."

For years, patients have shouted to be heard. But as online patient communities,
chat rooms and forums have gained popularity—and political clout—their voices
are resonating. Now being used to paint real-world pictures of patient drug use,
data from online patient communities can no longer be ignored or dismissed. “The
history of medicine is that in many respects patients have been left out of the
conversation,” says Brian Loew, president of inspire.com. “I think patient
communities are a real opportunity to fix that.”

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/observing-patients-online-the-changing-face-of-research.html

Already, data from online patient communities are being used to deepen
understanding of the patient journey through illness, thus improving compliance,
informing patient-centred endpoints for clinical trials and influencing
reimbursement decisions. Such pools of patients are also being deployed to
conduct direct-to-patient clinical research, where patients are recruited and
monitored online, thus eliminating the need for clinical sites and
investigators. In the face of payer skepticism, however, the question is how
fast will it scale up? market research book

Report Overview
In Observing Patients Online: the changing face of research, FirstWord
investigates the role online patient communities can play in observational
research to enhance knowledge of how drugs are taken in the real world. Based on
expert interviews, research and studies, the report examines how the means to
recruit patients online and track their experience via patient-reported outcome
questionnaires and sensors in real-time has the potential to transform how
observational studies are conducted.

Key features
* Who takes the lead in commissioning observational research
* Typical studies being commissioned online
* How healthcare tracking is going mainstream
* Case study of UCB’s partnership with PatientsLikeMe
* Benefits of crowdsourcing: is it the new serendipity?
* The drivers of online observational research

Key Benefits
* Overview of how online patient communities are transforming observational
research
* Access to expert opinion from key leaders in the industry
* Discussion of conventional versus direct-to-patient trials

For more information kindly visit :  Observing
Patients Online: the changing face of research

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "New Research into Prescribing Practices
comparative effectiveness research (CER) in the US is not only shedding light on
comparing disease treatments."

Every day, doctors make hundreds of decisions. Decisions that affect patient
care, diagnosis, follow up and pharmaceuticals prescribed.  What influences
those choices? When it comes to prescribing habits, says Dr G Caleb Alexander, a
University of Chicago assistant professor of medicine, “this is one of the great
unknowns. It’s pretty tough to accurately identify the sources and magnitude of
influence that guides physician learning.”

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/new-research-into-prescribing-practices.html

Yet comparative effectiveness research (CER) in the US is not only shedding
light on comparing disease treatments, but prompting detailed examinations of
how doctors make prescribing decisions and the factors that sway them.

Report Overview
In New Research into Prescribing Practices, FirstWord reviews the role of
CER intelligence, the significant gaps it has identified in physician knowledge
and how CER information will shape the way that pharmaceutical firms promote
their products. Based on expert interviews and the latest research, the report
reveals the key factors influencing physician decisions, from formal education,
casual colleague conversations, insurance regulations and government subsidies
to continuing medical education, samples and even patient pressure.
market research book

Key features
* Compelling insight into how pharma can address prescribing trends
* Examination of CERs influence on pharma, patient care and academic detailing

* Expert insight into how new drug promotions can evolve
* Discussion of how promotions can impact doctor-patient relations
* Analysis of why some drugs are overprescribed while others are underutilized

* Charts and tables illustrating compliance, prescribing trends

Key Benefits
* Expert advice on how pharma and CER projects can influence physician
choice
* Insight into the dominant factors affecting prescribing habits

Key quotes
“Armed with this comparative information, doctors and patients can discuss
the pros and cons of medications to come up with one that best fits the
patient’s needs and preferences.” – Dr Carolyn M Clancy, director of AHRQ

CER is “the next stage in an evolution of research and knowledge development in
regard to medical intervention… Embracing CER is regarded as an essential step
for the innovative pharmaceutical industry.” – Marc L Berger, vice-president of
global health outcomes and David Grainger, global public policy director, Eli
Lilly

“It’s pretty tough to accurately identify the sources and magnitude of influence
that guides physician learning. This is one of those great unknowns. We know
that some sources are influential, but discussing exactly how influential and in
what settings is easier said than done.”
– Dr G Caleb Alexander, assistant professor of medicine, University of Chicago

For more information kindly visit :  New
Research into Prescribing Practices

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Health Technology Assessment (HTA): a
European perspective, FirstWord examines the current role of HTA in Europe, from
its impact on reimbursement and pricing to market access."

The bottom line: For payers facing tough financial crunches across Europe,
Health Technology Assessment (HTA) is becoming increasingly important. Not only
is HTA influencing reimbursement, it is having an impact on price and market
access.

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/health-technology-assessment-htaa-european-perspective.html

And it’s not surprising. With greater scrutiny over the clinical and financial
value of drugs, medical devices and procedures, HTA is increasingly being
accepted around the world. The European situation is somewhat different:
existing across multiple borders, the ‘Europeanisation’ agenda of HTA has
sparked debates about European-wide standards, the possibility of a single
agency governing HTA and the need for formalized cooperation.
market research book

Report Overview
In Health Technology Assessment (HTA): a European perspective, FirstWord
examines the current role of HTA in Europe, from its impact on reimbursement and
pricing to market access. The report focuses on the experiences of five European
nations, reviewing the history of HTA and the key agencies in each. Written by
an expert health economist and with insight from experts from NICE, EUnetHTA ,
the EMA and leading pharmaceutical companies, the report reveals the problems,
pitfalls and—most importantly—the potential of a harmonized approach to HTA in
Europe.

Key features
* Detailed examination of the role of HTA in European pricing, reimbursement
and market access
* An overview of the role of HTA in Germany, France, Italy, Spain and the UK
* Country-by-country breakdown of key agencies
* Expert insight into the ‘Europeanisation’ of HTA and its key challenges
* Review of the potential and pitfalls

Key Benefits
* Full overview the role of HTA in Europe
* Insights from experts in the European Medicines Agency, the National Institute
for Health and Clinical Excellence and leading pharmaceutical companies
* Comprehensive references to key literature

Key Questions Asked
* What role does HTA play in pricing, reimbursement and market access?
* What is the current state of play with HTA across Europe?
* What changes are happening in HTA and what is their impact?
* Does one size fit all in terms of transferability and adaptability?
* What are the pitfalls, problems and potential of HTA in Europe?

For more information kindly visit :  Health
Technology Assessment (HTA): a European perspective

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Creating value stories that present a
pharmaceutical’s strongest case from a payer perspective is relatively new
territory. "

It’s an increasingly complex question faced by pharma companies when it comes to
creating compelling value stories for payers. With governments tightening purse
strings, generics flooding the market and the industry scrutinised with new
transparency requirements, finding ways to ‘think global and act local’ has
become critical and it is often not clear who is in charge.

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/creating-compelling-market-access-stories.html

Creating value stories that present a pharmaceutical’s strongest case from a
payer perspective is relatively new territory. Navigating the task means
creating stronger communication channels between the affiliates and the regional
or global centre as well as between R&D and commercial managers.

Report Overview
Creating Compelling Market Access Value Stories addresses the most
challenging questions facing market access by delving into how value stories are
created and managed. The report offers insight into the critical imperatives
surrounding their development and evolution. It discusses payer expectations,
how companies can ensure that all departments work from a market access
viewpoint and addresses practical issues such as testing the message and
ensuring its consistency for each of the various stakeholders.

Key features
* An examination of the rising importance of market access across Europe and
the US
* A review of how value propositions are built and the question of ownership
* The structural challenges companies face in developing cross-functional market
access capabilities
* The importance of payer research in validating and testing the value story
* Managing political developments
* Charts covering European bodies responsible for HTA activities and
country-by-country measures for rational use of medicines in the EU

Key Benefits
* Concise conclusions on developing and implementing value propositions
* A European-focused picture of how market access value stories are developed
* Expert input on everything from payer research to creating communication
channels across multiple company layers

Key Questions Asked
* Why are market access considerations now underpinning every aspect of the
pharmaceutical business?
* What are the major trends in healthcare technology assessment (HTA)?
* How can companies ensure they meet payer needs?
* When should companies test value stories, and how are tests best conducted?
* How can companies ensure consistency in value stories to all stakeholders?
* What is the importance of keeping current with political developments?

For more information kindly visit :  Creating
compelling market access stories

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Biobetters: Major Players and Market
Prospects the report reviews the role biosimilars have played, presents the
rationale behind biobetters and how interest is is stirring in their
development."

Even so, interest in biobetters is increasing, since they can and will command
higher prices while providing a significant improvement to the reference drug.
At the forefront of those turning to biobetters are branded pharma, biotech and
large generic companies who have already established themselves in the
biosimilars industry. But will the emerging biobetter industry prove to be more
lucrative than has been the case for biosimilars?

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/biobetters-major-players-and-market-prospects.html

Report Overview
In Biobetters: Major Players and Market Prospects (2nd edition), FirstWord
describes the biobetters market and how interest has mounted in what is still a
very young market. The report reviews the role biosimilars have played, presents
the rationale behind biobetters and how interest is is stirring in their
development. In addition, the report concisely outlines how companies are
evolving biobetters, the areas of greatest potential and reviews the ‘Achilles
Heel’ of immunogenicity. Based on frontline expert interviews, the report
addresses the question of approval pathways, who the major players are and,
perhaps most importantly, offers a compelling picture of biobetters’ future
prospects. market research book

Key features
* A comprehensive overview of the nascent biobetters market and where it is
going
* An outline of what biobetters are, how they are being developed and what their
likely targets are
* A discussion of the regulatory landscape
* An insight into the biobetters manufacturers of tomorrow
* An overview of optimal strategies for success

Key Benefits
* Access to top expert opinion and insights
* Compelling overview of the biobetters industry
* Frontline reporting on how it’s evolving and who will be the industry leaders

For more information kindly visit :  Biobetters:
Major Players and Market Prospects

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "This makes Si a better candidate for
solar cells as compared to other semiconductor material such as gallium arsenide
(GaAs) or germanium (Ge)."

Direct energy conversion from sunlight to electricity is obtained through solar
cells. Advantage of solar cells is that they do not have any mechanical parts
which make them easy to use, maintenance free and leading to longer life.
Silicon (Si) is widely used semiconductor material for solar cells. Advantage of
Si over other semiconductor devices is due to well developed microelectronics
industry which has considerable knowledge of working with Si. This makes Si a
better candidate for solar cells as compared to other semiconductor material
such as gallium arsenide (GaAs) or germanium (Ge).

http://www.bharatbook.com/market-research-reports/consumer-electronics-market-research-report/high-efficient-crystalline-silicon-solar-cells-competitor-and-ip-landscape-report-key-players-innovators-and-industry-analysis.html

The present efficiency limit and cost of the solar cell are not in comparison
with conventional energy sources. Efficiency of solar cells is about 24.7% in
laboratory and 14% commercially. Some practices which are followed to reduce the
losses are better material selection, proper manufacturing techniques or
changing design procedure of the cell. Low efficiency is due to high percentage
of losses. Reflection loss, resistive loss, recombination loss and thermal loss
tend to reduce the efficiency of solar cell. The present report discusses in
detail the different mechanisms of losses occurring in the solar cells. Also
techniques that are implemented to reduce, losses are addressed briefly.
market research

Method of analysis:
Efficiency improvement of crystalline Silicon solar cells IP analyses
started with identification of control patents which are highly relevant to the
topic. It follows the identification of various keywords related to the concept
and also identifying IPC, ECLA, US, F-term and DWPI classes relevant to the
context. Logical combinations of the classes and keywords are framed and are
searched in Thomson Innovation (TI) database. The search resulted in a total of
4706 INPADOC patent families, out of which 2425 patents have been identified as
relevant. These patents are used for further analytics.

Key findings:
From the analytics, it is observed that Sharp Corp, Mitsubishi Corporation
and Canon Inc is the major players in high efficiency crystalline silicon solar
cells. Also IP activity based on publication year and priority year is observed
and the trend shows that since 2005 there is considerable growth in the
research. Among the top players Canon KK, Sandia Corp and BP Corp North America
Inc have good number of cited patents and among technologies. H01L31/04
(Semiconductor Devices as Photovoltaic Converters) and H01L31/042 (Solar Cell
Arrays) have good quality patents. Top cited patents and article list has also
been furnished in the report.

For more information kindly visit :  High
Efficient Crystalline Silicon Solar Cells – Competitor and IP Landscape Report

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Global petrochemical infrastructure is both
adding capacity to accommodate larger volumes of primary petrochemicals, as well
as to produce more sophisticated petrochemicals that have specific qualities."

The petrochemical infrastructure market has seen rapid growth over the past
decade. Growth in demand for petrochemical products has been the major
underlying driver of growth. The manufacturing and production of modern
industrial and consumer goods requires polymers and derivatives of
petrochemicals which are integral to almost every product. There is no sign of a
change in this practice, as petrochemicals can provide a low cost and optimal
product for the majority of manufacturing situations. Visiongain calculates
global investment in the petrochemical infrastructure market will reach $64.1bn
in 2012.

http://www.bharatbook.com/market-research-reports/oil-and-gas-market-research-report/the-petrochemical-infrastructure-market-2012-2022.html

Global petrochemical infrastructure is both adding capacity to accommodate
larger volumes of primary petrochemicals, as well as to produce more
sophisticated petrochemicals that have specific qualities. Some of the most
advantageous properties of petrochemicals are their high strength, low density,
inert characteristics and their relatively low price that make them suitable for
use in many scenarios from the packaging of food and drinks to clothing.
Meanwhile, other high strength petrochemical materials and adhesives are widely
used in the construction industry. 
market research report

The major trends in the petrochemical infrastructure market are outlined in this
report. This report also evaluates various drivers and restraints of the market
in order to provide readers with specific insights into the future direction of
the petrochemical infrastructure market.

How much is going to be spent in the leading regional markets on petrochemical
infrastructure between 2012 and 2022? Who are the leading companies in this
industry? Where are the growth opportunities over the next decade – in which
countries? Which primary petrochemicals will see the most significant growth?
These critical questions and many more are answered in this comprehensive
report.

Unique Selling Points
• Global petrochemical infrastructure market forecasts and analysis for
2012-2022.
• 128 tables, charts and graphs quantifying, analysing and forecasting the
petrochemical infrastructure market from 2012-2022.
• Analysis and forecasts informed by consultation with industry expert opinion.
A full transcript of an interview from a leading company involved in
petrochemical infrastructure is included.
• Market forecasts and analysis for the 7 leading regional petrochemical
infrastructure markets, with market information and analysis on 35 national
markets and the rest of the world regions.
• Submarket forecasts from 2012-2022 for major primary petrochemical markets.
• Profiles of 65 leading companies within the petrochemical infrastructure
market.
• SWOT analysis of strengths, weaknesses, opportunities and threats facing the
petrochemical infrastructure market over the next ten years.
• Examination of the main trends in the petrochemical infrastructure market

Comprehensive analysis of the Petrochemical Infrastructure Market
The Petrochemical Infrastructure Market 2012-2022 examines this important
sector critically. We supply a comprehensive review of the market via analysis
of policy documents, news reports, industry publications, market analysis and
consultations with experts. This report provides detailed market forecasts, a
SWOT analysis, details of the leading companies in the market, and analyses of
commercial drivers and restraints. There is an original interview with a major
company in the industry which provides insight into different aspects of the
petrochemical infrastructure market. You will not find this analysis anywhere
else.

For more information kindly visit :  The
Petrochemical Infrastructure Market 2012-2022

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "The soldier modernisation market has begun to
emerge over recent years as various national programmes have developed from
their conceptual origins in the 1990s to become reality."

The soldier modernisation market has begun to emerge over recent years as
various national programmes have developed from their conceptual origins in the
1990s to become reality. Leading military nations have demonstrated a
determination to equip large numbers of troops with suites of soldier
modernisation equipment, and Visiongain’s calculations indicate that the value
of the soldier modernisation market will reach $802.4m in 2012.

http://www.bharatbook.com/market-research-reports/defense-market-research-report/the-soldier-modernisation-market-2012-2022.html

The global soldier modernisation market is expected to grow significantly over
the forecast period as the continual digitisation of the modern battlefield has
convinced many nations of the imperative to field infantry capable of utilising
tools such as advanced navigation, as well as communication and targeting
equipment. These needs are particularly pressing when conducting
counterinsurgency (COIN) operations against disparate and unconventional forces
with an intimate knowledge of local terrain. 
market research report

Ongoing technological advances in fields including powered exoskeletons and fuel
cells will help to drive the soldier modernisation market over the next decade,
while the most immediate restraint on the market will be the effects of the
continued global financial crisis, most acutely felt in Europe and North
America, which has led to cuts in defence budgets and delay or cancellation
characterising some soldier modernisation programmes (SMPs). Overall, a more
incremental approach to soldier modernisation procurement has begun to
materialise, however this trend is less pronounced in many emerging nations,
particularly in the Asia-Pacific region, where military budgets continue to rise
and the political will to embark upon SMPs exists. This is most true of the BRIC
(Brazil, Russia, India and China) powers.

The report contains 162 tables, charts and graphs that add visual analysis in
order to explain developing trends within the soldier modernisation market.
Visiongain provides forecasts for the period 2012-2022 in terms of value (US$)
for the soldier modernisation market as well as for 5 submarkets (C4I/C4ISR,
lethality, sustainability, survivability and mobility) that together form the
overall market figure. These soldier modernisation markets are quantified,
analysed and forecast from 2012-2022, alongside 21 leading national soldier
modernisation markets and 2 regional markets. The report provides profiles of 21
leading companies operating within the market, and includes 3 interviews with
important figures in the field of soldier modernisation, providing expert
insight.

Unique Selling Points
• A comprehensive analysis of the soldier modernisation market with detailed
forecasts provided from 2012-2022.
• Analysis and forecasting which has been underpinned by consultation with
experts from within the field of soldier modernisation. Within the report are 3
full transcripts from interviews conducted with Thales Norway, ITT Corporation
and the War Studies Department of King’s College London.
• Forecasts for 5 soldier modernisation submarkets from 2012-2022.
• Forecasts for the 23 leading soldier modernisation markets, as well as rest of
the world summaries and projections for the period 2012-2022.
• 162 tables, charts, and graphs quantifying and forecasting the soldier
modernisation market in detail from 2012-2022.
• A SWOT and a PEST analysis that examines the soldier modernisation market.
• Profiles of 21 leading companies operating within the soldier modernisation
market.

This definitive report should prove invaluable to anyone currently involved in
the soldier modernisation market or those who wish to enter this dynamic and
fast-growing sector.
This report has been compiled by combining information gleaned from a wide range
of primary and secondary research sources, producing a broad industry overview.
Visiongain sought opinions from leading figures in the soldier modernisation
market to underpin the analysis of market drivers and restraints. The study
draws on a diverse range of official corporate and governmental announcements,
media reports, policy documents, industry statements and expert opinion as a
basis for discussing and predicting developments in the soldier modernisation
market between 2012 and 2022. Visiongain considers that this methodology results
in an accurate, objective mixture of analyses and forecasts.

For more information kindly visit :  The
Soldier Modernisation Market 2012-2022

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Apple announced another shocking news about
the death of its former CEO Steve Jobs."

On October 4, 2011, Apple’s new CEO Timothy Cook unveiled a new iPhone, dubbed
the iPhone 4S, instead of the long-anticipated iPhone 5. On October 6, 2011,
Apple announced another shocking news about the death of its former CEO Steve
Jobs. While Apple received tremendous market criticism at the beginning of the
iPhone 4S launch, the passing of Steve Jobs also dropped a bomb to the mobile
communications industry worldwide.

http://www.bharatbook.com/market-research-reports/mobile-and-telecoms-market-research-report/apples-iphone-4s-strategy-and-its-implications-for-future-smartphone-development.html

This report offers insights into the recent two incidents of Apple, iPhone 4S
strategy and Steve Jobs’ recent demise, and their implications to the future
Smartphone development.
1. Incident One: the Release of iPhone 4S
1.1 iPhone 4S Features and Specs
1.2 Apple’s Strategy with iPhone 4S
1.2.1 Teaming up with More Telecom Operators
1.2.2 Product Positioning and Pricing
1.2.3 Focusing on Bettering User Experience in Lieu of Spec Upgrade
2. Incident Two: the Death of Steve Jobs
MIC Perspective
Appendix market research report

List of Topics
Background introduction, including features and specs of iPhone 4S, iPhone 4
and flagship models released by Apple’s major rivals, as well as Apple’s
strategy with iPhone 4S, such as teaming up with more telecom operators and
product positioning and pricing
Impacts brought by the death of Steve Jobs on Apple, touching on the roles of
Timothy Cook and Jonathan Ive
Analysis of iPhone 4S strategy in the Smartphone market, covering both high-end
and value-line model segments, and Apple’s relationship with supply chain
manufacturers
Companies and organizations analyzed or mentioned in the report include: Apple,
AT&T, China Telecom, Exxon Mobil, HTC, Samsung, Sprint


For more information kindly visit :  Apple’s
iPhone 4S Strategy and its Implications for Future Smartphone Development

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Apple unveiled its new iOS 5 mobile platform
at the Apple WWDC (Worldwide Developers Conference) 2011. "

Apple unveiled its new iOS 5 mobile platform at the Apple WWDC (Worldwide
Developers Conference) 2011. Other than removing many inconvenience associated
with upgrading, Apple also added new features to its iOS 5 and addressed many
concerns of previous iPhone buyers regarding iOS mobile platform in a bid to
compete head to head with the Google Android OS. In addition, Apple’s iCloud was
launched to replace MobileMe, which was originally cost at US$99 per year. The
releases of iOS 5 and iCloud are expected to begin to take their toll on the
industry.

http://www.bharatbook.com/market-research-reports/mobile-and-telecoms-market-research-report/apples-ios-5-and-icloud-features-and-their-implications-for-the-future-trends-of-mobile-os-platforms.html

This report analyses innovations and new business models of iOS5 and iCloud and
the subsequent challenges for iOS competitors and software developers.
2.New iOS 5 Features and Their Implications
2.1 Implications for iOS Competitors
2.1.1 Notification Center Helping iOS Keep Pace with Android OS
2.1.2 iMessage to Help Apple Make Inroads into Telecom Business
2.1.2.1 Bridging Apple’s Gap in Telecom Software
2.1.2.2 Providing Seamless Communications across Devices
2.1.3 Newsstand Eroding Market Share of Amazon Kindle
2.1.4 Apple-Twitter Partnership to Prevent Facebook’s dominance of Social
Networks
2.2 Implications for Software Developers
2.2.1 Opportunities Generated by Aligning with Apple’s Product Development Plan

3.Insight into iCloud New Business Model
3.1 iCloud Highlighting iOS Features to Other Apple Devices
4.Conclusion market research report

List of Topics
Analysis of features of the Apple iOS 5 and iCloud and their implications on
iOS competitors and software developers, and the insight into iCloud new
business model
Companies and organizations analyzed or mentioned in the report include: Apple,
Facebook, Google, Microsoft

For more information kindly visit :  Apple’s
iOS 5 and iCloud Features and their Implications for the Future Trends of Mobile
OS Platforms

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "Branded vendors projected to put emphasis on
users in the next-generation era of mobile networks, and in this era. "

Major branded vendors projected to put emphasis on users in the next-generation
era of mobile networks, and in this era, the vendors will think beyond
boundaries, aiming to compete with one another and cooperate with telecom
operators, supply chain manufacturers, and application providers. The future
Smartphone industry is expected to focus on mid-range and value-line Smartphones,
the major operating systems will each face different challenges, and cloud
service and next-generation Internet standard are forecasted to once again
change market competition.

http://www.bharatbook.com/market-research-reports/mobile-and-telecoms-market-research-report/beyond-bounds-competition-among-major-branded-vendors-and-outlook-on-the-smartphone-industry.html

Industry Paradigm Shift and Next-Generation Mobile Network
Internet Ecosystem Moves From Web 1.0 to Web 3.0
Product Focus Shifts from Connecting People to Enriching Life
Revenue Creation Changes from Device-based to User-based Development
Market Competition Evolves from Company Conflicts to Group Clashes
Competitors Increase from Mobile Communications Vendors to Internet Service
Providers market research report

Beyond Bounds: Competition and Cooperation among International Communication
Branded Vendors
Beyond Bounds: Beyond Traditional Competition, Cooperation Strategies, and
Business Scopes
Diverse Product Offering: Increase User Stickiness
Patent Competition: Users Face Less Choices
Patent Lawsuit Competition: Strengthening R&D Capabilities to Raise Barriers to
Entry
Spec Competition: Product Spec Problems Gradually Emerge
Spec Competition: Developing Innovative Technology to Attract Future Users
Teaming Up with Telecom Operators: Participating in Value Activities to Create
Win-Win Situation
Supply Chain Cooperation: Strengthening Vertical Integration to Boost Core
Revenues
Cooperating with Application Providers: Enhancing User Experience with Complete
Service Platform
Trends and Outlook of the Smartphone Industry
Major Vendors: Google, Apple, Microsoft Each Has Its Individual Ecosystem

For more information kindly visit :  Beyond
Bounds: Competition among Major Branded Vendors and Outlook on the Smartphone
Industry

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.

Bharatbook added a new report on "This report provides insight into the
development trends of the Taiwanese tablet industry as well as the corresponding
application IC market "

Brand vendors from different industry segments have begun earmarking their
investments for tablet products since 2011. In the first quarter of 2011, the
Apple iPad 2 remained mainstream product and several tablet brands followed
suits in the second quarter to launch their respective tablet products. Driven
by branded vendors’ aggressive moves, the Taiwanese tablet industry’s shipment
volume is anticipated to be further spurred in 2012. This report provides
insight into the development trends of the Taiwanese tablet industry as well as
the corresponding application IC market volume such as application processors
and wireless communications ICs in late 2011 and beyond.

http://www.bharatbook.com/market-research-reports/consumer-electronics-market-research-report/the-taiwanese-tablet-industry-and-tablet-application-ic-market-2h-2011-recap-and-1h-2012-forecast.html

1.Taiwanese Tablet Shipment Volume and Value
2. Taiwanese Tablet Product Shipment by Product Specifications
2.1 Screen Size
2.2 Operating System
2.3 Communications Technology
3.Taiwanese Tablet Industry Shipment by Business Type
4. Conclusion
4.1 Apple and Amazon Have Their Toll on the Taiwanese Tablet Industry Throughout
2011
4.2 The Table Industry Has Tendency towards Polarization
5. The Application Processor Market market
research report

5.1 Market Volume
5.2 Buyer-Supplier Relationship
6. The Wireless Communications IC Market
6.1 Market Volume
6.1.1 Wi-Fi Chip
6.1.2 3G Chip


For more information kindly visit :  The
Taiwanese Tablet Industry and Tablet Application IC Market, 2H 2011 Recap and 1H
2012 Forecast

Or   

Contact us at :

Bharat Book Bureau
Ph.: +91 22 27810772 / 27810773
Fax: 0091 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:

http://twitter.com/#!/Sandhya3B

ListFree.org: Embedded data.